These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8734664)

  • 21. Severe adverse drug reactions due to pseudoephedrine from over-the-counter medications.
    Assier-Bonnet H; Viguier M; Dubertret L; Revuz J; Roujeau JC
    Contact Dermatitis; 2002 Sep; 47(3):165-82. PubMed ID: 12492550
    [No Abstract]   [Full Text] [Related]  

  • 22. Bullous nonpigmenting multifocal fixed drug eruption due to pseudoephedrine in a combination drug: clinical and diagnostic observations.
    Bellini V; Bianchi L; Hansel K; Finocchi R; Stingeni L
    J Allergy Clin Immunol Pract; 2016; 4(3):542-4. PubMed ID: 26795640
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythrodermic cutaneous adverse drug reaction to oral pseudoephedrine confirmed on patch testing.
    Millard TP; Wong YW; Orton DI
    Contact Dermatitis; 2003 Nov; 49(5):263-4. PubMed ID: 14996054
    [No Abstract]   [Full Text] [Related]  

  • 24. Generalized fixed drug eruption caused by pazufloxacin.
    Sawada Y; Nakamura M; Tokura Y
    Acta Derm Venereol; 2011 Sep; 91(5):600-1. PubMed ID: 21597677
    [No Abstract]   [Full Text] [Related]  

  • 25. Ephedrine-induced erythrodermia: Clinical diagnostic procedure and cross-sensitivity.
    Tanno LK; Fillard A; Landry Q; Ramdane C; Bourrain JL; Demoly P; Chiriac AM
    Contact Dermatitis; 2018 Jul; 79(1):43-44. PubMed ID: 29573348
    [No Abstract]   [Full Text] [Related]  

  • 26. Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test.
    Sánchez TS; Sánchez-Pérez J; Aragüés M; García-Díaz A
    Contact Dermatitis; 2000 May; 42(5):312-3. PubMed ID: 10789874
    [No Abstract]   [Full Text] [Related]  

  • 27. Systemic contact dermatitis from pseudoephedrine.
    Tomb RR; Lepoittevin JP; Espinassouze F; Heid E; Foussereau J
    Contact Dermatitis; 1991 Feb; 24(2):86-8. PubMed ID: 1828222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact sensitivity and systemic reaction to pseudoephedrine and lignocaine.
    Downs AM; Lear JT; Wallington TB; Sansom JE
    Contact Dermatitis; 1998 Jul; 39(1):33. PubMed ID: 9686978
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fixed drug eruption induced by sulfaguanidine].
    Kastalli S; El Aidli S; Daghfous R; Trabelsi S; Lakhal M; Loueslati MH; Belkahia C
    Ann Dermatol Venereol; 2004 Apr; 131(4):382-4. PubMed ID: 15258515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed drug eruption from piroxicam.
    Gastaminza G; Echechipía S; Navarro JA; Fernández de Corrés L
    Contact Dermatitis; 1993 Jan; 28(1):43-4. PubMed ID: 8428451
    [No Abstract]   [Full Text] [Related]  

  • 31. Baboon syndrome due to pseudoephedrine.
    Sánchez-Morillas L; Reaño Martos M; Rodríguez Mosquera M; Iglesias Cadarso A; Pérez Pimiento A; Domínguez Lázaro AR
    Contact Dermatitis; 2003 Apr; 48(4):234. PubMed ID: 12786741
    [No Abstract]   [Full Text] [Related]  

  • 32. Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin.
    Asano A; Sowa-Osako J; Umekoji-Hayashi A; Teramae A; Fukai K; Tsuruta D
    Contact Dermatitis; 2021 Nov; 85(5):590-591. PubMed ID: 34129244
    [No Abstract]   [Full Text] [Related]  

  • 33. Fixed drug eruption (phenolphthalein). Evidence for a blood-borne mediator.
    Wyatt E; Greaves M; Sondergaard J
    Arch Dermatol; 1972 Nov; 106(5):671-3. PubMed ID: 4117910
    [No Abstract]   [Full Text] [Related]  

  • 34. Generalized dermatitis due to oral ephedrine.
    Villas Martínez F; Badas AJ; Garmendia Goitia JF; Aguirre I
    Contact Dermatitis; 1993 Oct; 29(4):215-6. PubMed ID: 8281792
    [No Abstract]   [Full Text] [Related]  

  • 35. Ephedrine-induced maculopapular rash.
    Maul LV; Streit M; Grabbe J
    Contact Dermatitis; 2018 Sep; 79(3):193-194. PubMed ID: 29766529
    [No Abstract]   [Full Text] [Related]  

  • 36. Desquamating Nonpigmenting Fixed Drug Eruption With Onycholysis due to Amoxicillin in a Child: Cross-reactivity Study.
    Moya B; Vera A; Bazire R; Betancor D; Rodríguez Del Río P; Escudero C; Ibáñez MD
    J Investig Allergol Clin Immunol; 2020 Apr; 30(2):149-151. PubMed ID: 31751290
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute generalized exanthematous pustulosis associated with pseudoephedrine.
    Padial MA; Alvarez-Ferreira J; Tapia B; Blanco R; Mañas C; Blanca M; Bellón T
    Br J Dermatol; 2004 Jan; 150(1):139-42. PubMed ID: 14746629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonpigmenting fixed drug eruption after anesthesia.
    Desmeules H
    Anesth Analg; 1990 Feb; 70(2):216-7. PubMed ID: 2137310
    [No Abstract]   [Full Text] [Related]  

  • 39. Fixed drug eruption due to cimetidine.
    Inoue A; Teramae H; Hisa T; Taniguchi S; Chanoki M; Hamada T
    Acta Derm Venereol; 1995 May; 75(3):250. PubMed ID: 7653194
    [No Abstract]   [Full Text] [Related]  

  • 40. Accidental intra-arterial adrenaline administration.
    Young RJ; Lipman J; Freebairn RC
    Anaesth Intensive Care; 1995 Aug; 23(4):488-9. PubMed ID: 7485943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.